Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International, Multicentre, Randomized Phase III Study of Rituximab as Maintenance Treatment Versus Observation Alone in Patients With Chronic Lymphocytic Leukemia

NCT01118234 is registered in ClinicalTrials.gov with Arbeitsgemeinschaft medikamentoese Tumortherapie as lead sponsor.

NCT NCT01118234
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01118234 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International, Multicentre, Randomized Phase III Study of Rituximab as Maintenance Treatment Versus Observation Alone in Patients With Chronic Lymphocytic Leukemia
Lead sponsor
Arbeitsgemeinschaft medikamentoese Tumortherapie
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2009
Completion date
July 31, 2019
Enrollment
256 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukemia